dyslipidaemia Flashcards

1
Q

definition of dyslipidaemia

A

Hypercholesterolaemia, an elevation of total cholesterol (TC) and/or low-density lipoprotein cholesterol (LDL-C) or non-high-density lipoprotein cholesterol (HDL-C) (defined as the subtraction of HDL-C from TC) in the blood,

often referred to as dyslipidaemia because - might be accompanied by a decrease in HDL-C, an increase in triglycerides, or qualitative lipid abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

lipid transport

A

Lipids travel in blood packaged with proteins as lipoproteins. There are four classes: chylomicrons and VLDL (mainly triglyceride), LDL (mainly cholesterol), and HDL (mainly phospholipid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RF for dyslipidaemia

A

FH

corneal arcus <50yrs

xanthomata/xanthelasmata

insulin resistence and t2dm

BMI >25kg/m2

hypothyroidism

cholestatic liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

types of hyperlipidaemia

A

common primary hyperlipidaemia

familial primary hyperlipidaemia

secondary hyperlipidaemia

mixed hyperlipidaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

common primary hyperlipidaemia

A

70% of hyperlipidaemia

raised LDL only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

familial primary hyperlipidaemia

A

multiple phenotypes

risk of increased CVD

protection from CVD achieved with lower doses of statin than for common primary hyperlipidaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

secondary hyperlipidaemia

A

raised LDL

treat the cause first

causes include:

  • cushings syndrome
  • hypothyroidism
  • nephrotic syndrome
  • cholestasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mixed hyperlipidaemia

A

both high LDL and triglycerides

causes

  • t2dm
  • metabolic syndrome
  • alcohol abuse
  • chronic renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

epidemiology of dyslipidaemia

A

Half the UK population have a serum cholesterol putting them at significant risk of CVD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

sx of dyslipidaemia

A

FH of early onset coronary heart disease or dyslipidaemia in 1st degree relatives

history of CVS disease

consumption of saturated fats and trans-fatty acids

excess body weight - especially abdo obesity

xanthelasmas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

signs of dyslipidaemia

A

xanthomata - yellow lipid deposits may be:

  • eruptive - itchy nodules in crops in hypertrigluceridaemia
  • tuberous - plaques on elbows and knees
  • planar (palmar) - orange streaks in palmar creases
  • tendons
  • eyelids - xanthelasma
  • corneal arcus
  • diagnostic of remnant hyperlipidaemia

lipaemia retinalis - When viewed through the ophthalmoscope, the retina is pale and the retinal vessels are white.

dm

coronary artery disease

angina/claudication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ix for dyslipidaemia

A

fasting TG - ≥2.3 mmol/L (200 mg/dL)

lipid profile - Consists of TC, triglycerides, and LDL-, HDL-, and non-HDL-cholesterol.

  • total cholesterol (TC) >5.18 mmol/L (>200 mg/dL);
  • LDL-cholesterol >2.59 mmol/L (>100 mg/dL);
  • non-HDL-cholesterol <3.4 mmol/L (<130 mg/dL);
  • HDL-cholesterol <1.04 mmol/L (<40 mg/dL) for men and <1.29 mmol/L (<50 mg/dL) for women;
  • triglycerides >1.7 mmol/L (>150 mg/dL)

TSH - elevated in primary hypothyroidism

lipoprotein (a) - Lipoprotein(a) is an LDL particle with apolipoprotein(a) covalently bound to apolipoprotein B of LDL.

  • values >50 mg/dL or >125 nmol/L are considered high
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

treatment priorities for dyslipidaemia

A

identify familial or secondary hyperlipidaemias

top priority - people with known CVD

second - primary prevention in pts with chronic kidney disease or t1dm, and those with a 10yr risk of CVD >10% irrespective of baseline lipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

1st line mx of dyslipidaemia

A

atorvastatin 20mg PO at night for primary prevention, 80mg for secondary prevention and primary prevention in the people that have kidney disease

Simvastatin 40mg, is an alternative.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mechanism of statins

A

reduce cholesterol synthesis in the liver by inhibiting HMGCOA reductase

CI: porphyria, cholestasis, pregnancy

SE: myalgia +- myositis (stop if increasing CK≥10-fold; if any myalgia, check CK; risk is 1 per 100000 treatment-years), abdo pain and raised LFTs (stop if AST >100u/L)

Cytochrome P450 inhibitors increase serum concentrations - grapefruit juice

target plasma cholesterol reduction of ≥40 % in those with CVD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2nd line mx of dyslipidaemia

A

Ezetimibe—a cholesterol absorption inhibitor,

may be used in statin intolerance or combination with statins to achieve target reduction

17
Q

3rd line Mx of dyslipidaemia

A

Alirocumab—a monoclonal antibody against PCSK9 (acts to reduce hepatocyte LDL receptor expression).

  • Very effective in reducing LDL
  • expensive and injection every 2wks

fibrates eg bezafibrate (useful in mixed hyperlipidaemias)

anion exhange resins eg cholestyramine

nicotinic acid - raise HDL, lower LDL

  • SE: severe flushes - aspirin 300mg ½h pre-dose helps this
18
Q

what does hypertrigluceridaemia respond best to

A

fibrates, nicotinic acid, or fish oil.

19
Q

complications of dyslipidaemia

A

coronary events

acute pancreatitis

IHD

PVD

acute coronary syndrome

stroke

erectile dysfunction

20
Q

Px of dyslipidaemia

A

improved significantly with lowering of triglyceride levels

require ongoing long-term therapy with monitoring of plasma lipids as well as side effects.

Once plasma lipid levels have achieved goals and are stable they can be monitored along with liver function tests every 6 months.

vast majority of patients do well with statin therapy without adverse events.